SG Americas Securities
TARS icon

SG Americas Securities’s Tarsus Pharmaceuticals TARS Stock Holding History

SG Americas Securities’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Sell
3,283
-11,099
-77% -$709K ﹤0.01% 2791
2026
Q1 		$1.01M Buy
14,382
+864
+6% +$60.4K ﹤0.01% 1755
2025
Q4 		$1.11M Buy
13,518
+7,339
+119% +$548K ﹤0.01% 1931
2025
Q3 		$367K Sell
6,179
-27,833
-82% -$1.37M ﹤0.01% 2352
2025
Q2 		$1.38M Buy
34,012
+28,789
+551% +$1.3M 0.01% 963
2025
Q1 		$268K Buy
5,223
+2,062
+65% +$102K ﹤0.01% 2305
2024
Q4 		$175K Sell
3,161
-4,081
-56% -$185K ﹤0.01% 2275
2024
Q3 		$238K Buy
7,242
+3,379
+87% +$95K ﹤0.01% 2350
2024
Q2 		$105K Sell
3,863
-6,811
-64% -$229K ﹤0.01% 2525
2024
Q1 		$388K Sell
10,674
-44,305
-81% -$1.3M ﹤0.01% 1547
2023
Q4 		$1.11M Buy
54,979
+4,266
+8% +$71.2K 0.01% 967
2023
Q3 		$901K Buy
50,713
+9,141
+22% +$162K 0.01% 1355
2023
Q2 		$751K Buy
+41,572
New +$661K 0.01% 1206
2022
Q3 		– Sell
-50,512
Closed -$737K – 3550
2022
Q2 		$737K Buy
50,512
+8,073
+19% +$121K 0.01% 1596
2022
Q1 		$714K Sell
42,439
-1,891
-4% -$35.1K 0.01% 1653
2021
Q4 		$997K Sell
44,330
-1,923
-4% -$50K 0.01% 1649
2021
Q3 		$997K Buy
46,253
+23,276
+101% +$576K ﹤0.01% 1909
2021
Q2 		$666K Buy
+22,977
New +$718K ﹤0.01% 1801

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SG Americas Securities's TARS Position: Q2 2026 in Review

SG Americas Securities reduced its Tarsus Pharmaceuticals (TARS) stake by 77% in Q2 2026, selling an estimated $709K and leaving 3,283 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

SG Americas Securities first reported a position in TARS in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.38M in Q2 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • SG Americas Securities held 3,283 shares of Tarsus Pharmaceuticals worth $207K as of Q2 2026.
  • SG Americas Securities sold 11,099 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $709K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2791 holding.
  • SG Americas Securities first reported a position in Tarsus Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • SG Americas Securities's Tarsus Pharmaceuticals position peaked at $1.38M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.